Cardiometabolic indices predict hypogonadism in male patients with type 2 diabetes

被引：0
|
作者：
N. Caretta
P. Facondo
S. Mereu
A. Delbarba
M. C. Crepaldi
M. Vedovato
A. Avogaro
A. Ferlin
机构：
[1] University Hospital of Padova,Unit of Andrology and Reproductive Medicine
[2] University of Brescia,Department of Clinical and Experimental Sciences
[3] University of Padova,Department of Medicine
[4] ASST Spedali Civili,Unit of Endocrinology and Metabolism
[5] University of Padova,Department of Medicine, Division of Metabolic Diseases
[6] University of Padova,Department of Medicine, Unit of Andrology and Reproductive Medicine
来源：
Journal of Endocrinological Investigation | 2023年 / 46卷
关键词：
Male hypogonadism; Metabolic syndrome; Testosterone; Type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：599 / 608
页数：9
相关论文
共 50 条
  • [31] Male hypogonadism: 15-year prospective outcome in 550 men with Type 2 diabetes
    Heald, A. H.
    Malipatil, N. S.
    Gibson, J. M.
    Moreno, G. Y. C.
    Livingston, M.
    Rutter, M. K.
    Donn, R. P.
    Hackett, G.
    Mumdzic, E.
    Jones, T. H.
    DIABETIC MEDICINE, 2018, 35 : 202 - 202
  • [32] Male hypogonadism: 14-year prospective outcome in 550 men with type 2 diabetes
    Malipatil, Nagaraj S.
    Yadegarfar, Ghasem
    Lunt, Mark
    Keevil, Brian
    Siddals, Kirk
    Livingston, Mark
    Roberts, Siriol
    Narayanan, Prakash
    Rutter, Martin
    Gibson, J. Martin
    Donn, Rachelle
    Hackett, Geoff
    Jones, T. Hugh
    Heald, Adrian
    ENDOCRINOLOGY DIABETES & METABOLISM, 2019, 2 (03)
  • [33] Age, Insulin Requirements, Waist Circumference, and Triglycerides Predict Hypogonadotropic Hypogonadism in Patients with Type 1 Diabetes
    Chillaron, Juan J.
    Fernandez-Miro, Merce
    Albareda, Merce
    Vila, Lluis
    Colom, Cristina
    Fontsere, Sara
    Pedro-Botet, Juan
    Flores-Le Roux, Juana A.
    JOURNAL OF SEXUAL MEDICINE, 2015, 12 (01): : 76 - 82
  • [34] The importance of treating cardiometabolic risk factors in patients with type 2 diabetes
    Barnett, Anthony H.
    DIABETES & VASCULAR DISEASE RESEARCH, 2008, 5 (01): : 9 - 14
  • [35] CARDIOMETABOLIC RISK ASSOCIATED WITH METABOLIC SYNDROME IN TYPE 2 DIABETES PATIENTS
    Torrea, M.
    Aladeazabal, N.
    Lopez Berastegui, O. L. G. A.
    Pinilla, B.
    Muino, A.
    Millan, J.
    ATHEROSCLEROSIS, 2014, 235 (02) : E237 - E238
  • [36] Adipokines as markers of cardiometabolic risk factors in patients with type 2 diabetes
    Abdella, Nabila
    Mojiminiyi, Olusegun
    Aldahi, Waleed
    Al Mohammedi, Hisham
    El Gebely, Soliman
    DIABETES, 2006, 55 : A399 - A399
  • [37] Sex differences in Cardiometabolic treatment among patients with type 2 diabetes
    Denig, Petra
    Vries, de Sieta T.
    Puijenbroek, van Eugene
    Mol, Peter G. M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 142 - 142
  • [38] Prevalence of hypogonadism in patients with type 2 diabetes mellitus among the Indian population
    Anupam, Biswas
    Shivaprasad, Channabasappa
    Vijaya, Sarathi
    Sridevi, Atluri
    Aiswarya, Yalamanchi
    Nikhil, Kumar
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2020, 14 (05) : 1299 - 1304
  • [39] The relationship between vitamin D and hypogonadism in patients with type 2 diabetes mellitus
    Dogan, H.
    Sargin, G.
    Harman, E.
    DIABETOLOGIA, 2014, 57 : S269 - S269
  • [40] NCEP-ATPIII-defined metabolic syndrome, type 2 diabetes mellitus, and prevalence of hypogonadism in male patients with sexual dysfunction
    Corona, Giovanni
    Mannucci, Edoardo
    Petrone, Luisa
    Balercia, Giancarlo
    Paggi, Francesca
    Fisher, Alessandra D.
    Lotti, Francesco
    Chiarini, Valerio
    Fedele, Domenico
    Forti, Gianni
    Maggi, Mario
    JOURNAL OF SEXUAL MEDICINE, 2007, 4 (04): : 1038 - 1045
12345